WVP
TELA icon

Worth Venture Partners’s TELA Bio TELA Stock Holding History

Worth Venture Partners’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,860
Closed -$21.9K – 79
2024
Q1 		$21.9K Sell
3,860
-341,471
-99% -$2.25M 0.15% 51
2023
Q4 		$2.29M Buy
345,331
+31,111
+10% +$180K 1.24% 26
2023
Q3 		$2.51M Sell
314,220
-99,021
-24% -$920K 1.49% 19
2023
Q2 		$4.19M Buy
413,241
+3,592
+0.9% +$36.7K 2.28% 13
2023
Q1 		$4.36M Sell
409,649
-6,149
-1% -$67.8K 2.13% 10
2022
Q4 		$4.78M Buy
415,798
+35,602
+9% +$319K 2.82% 7
2022
Q3 		$3.24M Buy
380,196
+267,184
+236% +$2.22M 1.98% 16
2022
Q2 		$904K Buy
+113,012
New +$938K 0.53% 56

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Worth Venture Partners's TELA Position: Q2 2024 in Review

Worth Venture Partners sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 3,860 shares — an estimated $21.9K sold.

Worth Venture Partners first reported a position in TELA in Q2 2022 and held it in 8 quarters. The position peaked at $4.78M in Q4 2022. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

  • Worth Venture Partners reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
  • Worth Venture Partners sold 3,860 TELA Bio shares in Q2 2024, an estimated $21.9K.
  • Worth Venture Partners first reported a position in TELA Bio in Q2 2022 and held it in 8 quarters.
  • Worth Venture Partners's TELA Bio position peaked at $4.78M in Q4 2022.
  • 68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.